- Datametrex (DM) has received approval for a normal course issuer bid (NCIB)
- Between June 8, 2022, and June 7, 2023, Datametrex may purchase up to 17,808,301 of its common shares
- All shares purchased will be cancelled
- Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning
- Datametrex AI Limited (DM) opened trading at C$0.14
Datametrex (DM) has received approval for a normal course issuer bid (NCIB).
Between June 8, 2022, and June 7, 2023, Datametrex may purchase up to 17,808,301 of its common shares. Purchases under the bid will be made by PI Financial Corp. on behalf of the company.
The NCIB is expected to benefit shareholders by increasing their equity interest in the company. All shares purchased will be cancelled.
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Datametrex provides solutions to support the supply chain.
Datametrex AI Limited (DM) opened trading at C$0.14.
